CLINICAL_TRIALS
trial_result
· 2021-10-08
Clinical Trial Update: Sertraline Pediatric Registry for the Evaluation of Safety (SPRITES)
Summary
A completed pediatric registry study evaluating the safety of sertraline for obsessive-compulsive disorder, with results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Obsessive Compulsive Disorder | Status: COMPLETED | Results posted: 2021-10-08